Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 3 minute read Healthcare Industry News Zimmer Biomet expands foot and ankle portfolio with $1.2bn Paragon 28 acquisition Zimmer Biomet Holdings, Inc. has entered into a definitive agreement to acquire Paragon 28, Inc., a leading medical… byPallavi MadhirajuJanuary 29, 2025